YOR161W-A Antibody

What is YOR161W-A and why is it significant for yeast research?

YOR161W-A is a systematic gene name for a protein in Saccharomyces cerevisiae, which serves as an important model organism in molecular biology. The "YOR" prefix indicates its location on chromosome XV, while "W-A" suggests it was identified as an additional open reading frame after initial genome annotation. This protein is significant for yeast research because it contributes to our understanding of fundamental cellular processes that are often conserved across eukaryotes, from simple unicellular organisms to complex multicellular ones such as humans . Antibodies against YOR161W-A enable researchers to study its expression, localization, and function in various experimental contexts.

What are the common applications of YOR161W-A antibody in basic research?

YOR161W-A antibody is primarily used in basic research for:

• Protein detection and quantification via Western blotting

• Protein localization studies using immunofluorescence microscopy

• Immunoprecipitation experiments to identify protein interaction partners

• Chromatin immunoprecipitation (ChIP) to study DNA-protein interactions if YOR161W-A has DNA-binding properties

• Monitoring protein expression changes during cellular stress responses or programmed cell death

These applications provide valuable insights into yeast cellular processes and can be extrapolated to understand similar mechanisms in higher eukaryotes, as S. cerevisiae is frequently used as a model system for understanding physiological processes in metazoan cells .

How does YOR161W-A antibody compare with other yeast protein antibodies in immunological assays?

When comparing YOR161W-A antibody with other yeast protein antibodies such as those targeting Ypt proteins (Ypt4, Ypt5, Ypt7, Ypt71), Yox1, or Yvh1 , researchers should consider several factors:

• Specificity: YOR161W-A antibody should be validated for minimal cross-reactivity with other yeast proteins

• Sensitivity: Detection limits may vary compared to antibodies against more abundant yeast proteins

• Application versatility: Some yeast antibodies perform better in certain applications (Western blot vs. immunofluorescence)

• Species cross-reactivity: Unlike some conserved yeast proteins, YOR161W-A-specific antibodies may not recognize homologs in other species

Antibody selection should be guided by the specific experimental requirements and the biological question being addressed.

How should I design experiments to study YOR161W-A during yeast stress response?

When designing experiments to study YOR161W-A during yeast stress response:

• Control selection: Include both positive and negative controls - unstressed cells and cells exposed to known stress inducers that affect similar pathways .

• Time course analysis: Perform time course experiments to capture early, intermediate, and late stress responses, as gene expression changes are among the earliest cellular responses .

• Stress conditions: Apply relevant stressors based on your hypothesis (oxidative stress, nutrient limitation, temperature shifts, etc.).

• Multiple detection methods: Combine techniques such as:

  • Western blotting with YOR161W-A antibody to quantify protein levels

  • qRT-PCR to measure mRNA levels

  • Fluorescence microscopy to track protein localization changes

• Multi-omics approach: Consider complementing antibody-based detection with RNA-seq to identify co-expressed genes during stress response .

• Paralog analysis: If YOR161W-A has paralogs, monitor their expression patterns simultaneously, as paralog substitution can be a specific marker for cell stress versus programmed cell death .

What controls are essential when using YOR161W-A antibody in immunoprecipitation experiments?

When performing immunoprecipitation experiments with YOR161W-A antibody, the following controls are essential:

• Input control: Sample of total protein extract before immunoprecipitation (typically 5-10%)

• Isotype control: Immunoprecipitation with isotype-matched non-specific antibody (e.g., human IgG) to identify non-specific binding

• Negative control:

  • Wild-type yeast extract without YOR161W-A expression

  • Immunoprecipitation without antibody

• Positive control:

  • Immunoprecipitation with antibody against a known interaction partner

  • If using tagged YOR161W-A, parallel immunoprecipitation with anti-tag antibody

• Validation control: Reverse immunoprecipitation with antibodies against identified interaction partners

• Technical replicates: At least three independent experiments to ensure reproducibility

Including these controls helps distinguish between specific YOR161W-A interactions and experimental artifacts, ensuring the reliability and validity of your findings.

How can I effectively use YOR161W-A antibody to investigate protein-protein interactions in yeast?

To effectively investigate YOR161W-A protein-protein interactions:

• Co-immunoprecipitation (Co-IP):

  • Use YOR161W-A antibody for immunoprecipitation, then probe for potential interaction partners

  • Alternatively, immunoprecipitate with antibodies against suspected partners and probe for YOR161W-A

  • Optimize lysis conditions to preserve physiologically relevant interactions

• Proximity labeling:

  • Express YOR161W-A fused to a proximity labeling enzyme (BioID or APEX2)

  • Identify proximal proteins by mass spectrometry after biotinylation

  • Validate candidates using YOR161W-A antibody in Co-IP experiments

• Yeast two-hybrid complementary approach:

  • Use yeast two-hybrid to identify potential interactors

  • Confirm interactions in vivo using YOR161W-A antibody in Co-IP experiments

• Functional validation:

  • Perform functional assays to test the biological relevance of identified interactions

  • Use YOR161W-A antibody to monitor changes in interaction dynamics under different conditions

• Interaction dynamics:

  • Study interaction changes during stress response or programmed cell death using time course experiments

  • Compare with paralog interactions to determine specificity, as research shows paralog substitution can be a marker for programmed cell death versus stress

What are the optimal conditions for using YOR161W-A antibody in Western blotting?

For optimal Western blotting results with YOR161W-A antibody:

Sample Preparation:

• Extract proteins using glass bead lysis in a buffer containing protease inhibitors

• Include phosphatase inhibitors if studying phosphorylation states

• Use fresh samples or store at -80°C with reducing agents to prevent oxidation

Gel Electrophoresis:

• Use 10-12% SDS-PAGE for optimal resolution of YOR161W-A

• Include positive control (purified YOR161W-A or overexpression lysate)

• Load 20-50 μg of total protein per lane

Transfer Conditions:

• Semi-dry or wet transfer at 100V for 1 hour (adjust based on protein size)

• Use PVDF membrane for better protein retention and signal

Blocking and Antibody Incubation:

• Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Dilute primary YOR161W-A antibody 1:1000 in blocking solution

• Incubate overnight at 4°C with gentle rocking

• Wash 3× with TBST, 10 minutes each

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour at room temperature

Detection:

• Use enhanced chemiluminescence (ECL) detection

• Optimize exposure time based on signal intensity

• Consider using stain-free technology for normalization instead of housekeeping proteins

Troubleshooting Tips:

• If signal is weak, increase antibody concentration or incubation time

• If background is high, increase washing time or add 0.1% Tween-20 to antibody dilution

• For multiple proteins of interest, strip and reprobe or use fluorescent secondary antibodies

How can I validate the specificity of YOR161W-A antibody for immunofluorescence studies?

To validate YOR161W-A antibody specificity for immunofluorescence:

• Genetic validation:

  • Test antibody on wild-type yeast and YOR161W-A deletion strains

  • Absence of signal in deletion strain confirms specificity

  • Use strains with YOR161W-A tagged with GFP/RFP to confirm co-localization

• Antibody absorption control:

  • Pre-incubate antibody with purified YOR161W-A protein

  • Loss of signal indicates specific binding

  • Include non-absorbed antibody control in parallel

• Secondary antibody control:

  • Omit primary antibody to check for non-specific secondary antibody binding

  • Use isotype control antibody (e.g., normal IgG) to assess background

• Subcellular fractionation correlation:

  • Compare immunofluorescence localization with subcellular fractionation results

  • Western blot different cellular fractions to confirm expected localization pattern

• Multiple antibody validation:

  • If available, test multiple antibodies recognizing different epitopes of YOR161W-A

  • Consistent localization patterns increase confidence in specificity

• Peptide competition assay:

  • Pre-incubate antibody with immunizing peptide

  • Signal should be abolished or significantly reduced

• Signal quantification:

  • Present quantitative data showing signal-to-noise ratio

  • Include statistical analysis from multiple cells and experiments

What protocols ensure reproducible ChIP results when using YOR161W-A antibody?

For reproducible Chromatin Immunoprecipitation (ChIP) with YOR161W-A antibody:

Cell Preparation:

• Harvest 50 ml of yeast culture at OD600 = 0.8-1.0

• Crosslink with 1% formaldehyde for 15 minutes at room temperature

• Quench with 125 mM glycine for 5 minutes

• Wash cells twice with ice-cold PBS

Chromatin Preparation:

• Lyse cells with glass beads in lysis buffer containing protease inhibitors

• Sonicate to generate DNA fragments of 200-500 bp

• Verify fragmentation by agarose gel electrophoresis

• Pre-clear chromatin with protein A/G beads for 1 hour at 4°C

Immunoprecipitation:

• Use 2-5 μg of YOR161W-A antibody per reaction

• Include IgG control and input samples (5-10% of chromatin)

• Incubate overnight at 4°C with rotation

• Add protein A/G beads and incubate for 2 hours at 4°C

• Wash beads thoroughly with low-salt, high-salt, LiCl, and TE buffers

DNA Recovery:

• Reverse crosslinks at 65°C overnight

• Treat with RNase A and Proteinase K

• Purify DNA using phenol-chloroform extraction or commercial kits

• Analyze by qPCR or sequencing

Critical Quality Controls:

• Technical replicates (minimum 3)

• Biological replicates (minimum 3)

• Positive control (known binding site for another transcription factor)

• Negative control (genomic region with no expected binding)

• Antibody performance validation before full-scale experiments

Data Analysis Best Practices:

• Normalize to input samples

• Apply appropriate statistical methods

• Identify enriched regions using established algorithms

• Validate key findings with independent methods (e.g., reporter assays)

How do I properly quantify and normalize Western blot data using YOR161W-A antibody?

For proper quantification and normalization of Western blot data:

Image Acquisition:

• Capture images within linear dynamic range

• Avoid saturated pixels which prevent accurate quantification

• Use a digital imaging system rather than film for better quantification

Quantification Method:

• Measure band intensity using ImageJ or similar software

• Subtract background from each band

• Calculate relative expression compared to control samples

Normalization Strategies:

Statistical Analysis:

• Perform minimum of three biological replicates

• Apply appropriate statistical tests (t-test, ANOVA)

• Present data as mean ± standard deviation/error

• Consider power analysis to determine sample size

Reporting Recommendations:

• Include representative blot images showing all experimental conditions

• Present quantification in graphical format with appropriate error bars

• Clearly state normalization method and statistical analysis performed

• Report antibody dilution, exposure time, and image acquisition parameters

What bioinformatic approaches can complement YOR161W-A antibody studies for understanding protein function?

Complementary bioinformatic approaches to enhance YOR161W-A antibody studies:

• Sequence Analysis:

  • Identify conserved domains and motifs

  • Predict post-translational modifications

  • Analyze evolutionary conservation across species

• Structural Prediction:

  • Generate protein structure models using AlphaFold2 or similar tools

  • Identify potential binding pockets and functional sites

  • Predict protein-protein interaction interfaces

• Co-expression Network Analysis:

  • Analyze RNA-seq data to identify co-expressed genes

  • Use weighted correlation network analysis (WGCNA) to identify functional modules

  • Compare expression patterns during stress response versus programmed cell death

• Pathway Enrichment Analysis:

  • Identify biological pathways enriched among co-expressed genes

  • Use Gene Ontology (GO) to determine molecular functions and cellular components

  • Apply Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis

• Interactome Analysis:

  • Integrate protein-protein interaction data from databases

  • Predict functional partners using STRING or BioGRID

  • Visualize interaction networks with Cytoscape

• Differential Expression Analysis:

  • Compare YOR161W-A expression across different conditions

  • Identify situations where paralogs show substitution patterns

  • Analyze expression in stress response versus programmed cell death

• Paralog Analysis:

  • Examine expression patterns of paralog pairs during different conditions

  • Compare substitution patterns in stress versus programmed cell death

  • Identify condition-specific regulation of paralog expression

How can I integrate YOR161W-A antibody data with transcriptomic analyses for comprehensive understanding?

To integrate YOR161W-A antibody data with transcriptomics:

• Time-Course Integration:

  • Collect protein samples (for antibody detection) and RNA samples (for transcriptomics) from the same experiment at multiple time points

  • Compare protein expression kinetics with mRNA expression profiles

  • Identify potential post-transcriptional regulation by examining time lags between mRNA and protein changes

• Multi-Omics Data Analysis Framework:

  • Normalize protein quantification data from Western blots

  • Process RNA-seq data using standard pipelines to obtain normalized counts (CPM/RPKM)

  • Use dedicated multi-omics analysis tools (mixOmics, MOFA)

  • Apply dimensionality reduction techniques to visualize relationships

• Correlation Analysis:

  • Calculate Pearson or Spearman correlation between YOR161W-A protein levels and transcript levels

  • Identify genes with correlated or anti-correlated expression patterns

  • Create correlation heatmaps to visualize relationships

• Gene Set Enrichment Analysis:

  • Perform GSEA on genes correlated with YOR161W-A protein expression

  • Identify enriched biological processes and pathways

  • Compare with pathways identified in programmed cell death studies

• Network Construction:

  • Build integrated protein-mRNA networks

  • Identify hub genes that may regulate or be regulated by YOR161W-A

  • Apply weighted gene correlation network analysis (WGCNA) to identify co-expression modules

• Visualization Strategies:

  • Create integrated heatmaps showing protein and mRNA expression patterns

  • Use scatter plots to show protein vs. mRNA correlation

  • Develop pathway maps highlighting protein and transcript changes

• Validation Approaches:

  • Confirm key findings with orthogonal methods

  • Use YOR161W-A antibody to validate protein changes in independent samples

  • Consider genetic perturbation (deletion or overexpression) to test hypothesized relationships

Why might I see inconsistent results with YOR161W-A antibody in different experiments?

Several factors can contribute to inconsistent results with YOR161W-A antibody:

• Antibody Quality Issues:

  • Lot-to-lot variability in commercial antibodies

  • Degradation due to improper storage or repeated freeze-thaw cycles

  • Denaturation from improper handling

• Experimental Variation:

  • Inconsistent sample preparation methods

  • Variations in cell growth conditions affecting YOR161W-A expression

  • Different buffer compositions affecting epitope accessibility

• Technical Variables:

  • Inconsistent blocking conditions

  • Variations in incubation times or temperatures

  • Different detection systems or imaging parameters

• Biological Factors:

  • Cell cycle-dependent expression of YOR161W-A

  • Stress responses affecting expression (even minor variations in culture conditions)

  • Post-translational modifications altering epitope recognition

  • Paralog expression changes under different conditions

• Sample-Specific Issues:

  • Protein degradation during sample preparation

  • Interference from other cellular components

  • Cross-reactivity with similar proteins

Recommended Solutions:

• Validate antibody specificity using knockouts or knockdowns

• Standardize experimental protocols and sample preparation

• Include appropriate controls in every experiment

• Maintain detailed records of experimental conditions

• Consider using epitope-tagged versions of YOR161W-A as alternative detection method

How can I distinguish between specific and non-specific signals when using YOR161W-A antibody?

To distinguish between specific and non-specific signals:

• Genetic Controls:

  • Test antibody in YOR161W-A deletion strain

  • Compare wild-type with YOR161W-A overexpression strain

  • Use epitope-tagged YOR161W-A strain and compare with tag-specific antibody results

• Antibody Validation:

  • Perform peptide competition assay

  • Compare results from antibodies recognizing different YOR161W-A epitopes

  • Use isotype control antibody at same concentration

• Technical Approaches:

  • Optimize antibody dilution with titration experiments

  • Use more stringent washing conditions to reduce background

  • Employ gradient gels for better separation of similar-sized proteins

  • Pre-adsorb antibody with yeast lysate from YOR161W-A deletion strain

• Signal Characteristics Analysis:

  • Specific signals should appear at predicted molecular weight

  • Specific signals should change predictably with experimental conditions

  • Non-specific bands typically remain constant across conditions

  • Compare band pattern with published literature or database information

• Quantitative Assessment:

  • Calculate signal-to-noise ratio

  • Perform statistical analysis of replicates

  • Compare signal intensity between specific and control samples

What are the best practices for storage and handling of YOR161W-A antibody to maintain its activity?

For optimal antibody maintenance:

Storage Conditions:

• Store concentrated antibody stocks at -20°C or -80°C in small aliquots

• Avoid repeated freeze-thaw cycles (limit to <5)

• For working dilutions, store at 4°C with preservative (0.02% sodium azide)

• Protect from light if fluorescently conjugated

Handling Guidelines:

• Allow antibody to equilibrate to room temperature before opening

• Centrifuge briefly before opening to collect solution

• Use sterile technique when handling antibody solutions

• Return to appropriate storage temperature promptly after use

Stability Considerations:

Quality Control Practices:

• Record date of receipt and first use

• Note lot number and source

• Periodically test activity against reference samples

• Document performance in standardized assays

Reconstitution (if lyophilized):

• Use recommended buffer (typically PBS)

• Allow complete dissolution before use

• Consider adding stabilizers (BSA, glycerol)

• Filter sterilize if storing for extended periods

By following these guidelines, researchers can maximize antibody performance and experimental reproducibility when working with YOR161W-A antibody.